Obermatt
See Similar Stocks →

enGene

NAQ:ENGN · CA29286M1059
BiotechnologySmall

360° View

no current rank
Price/Sales28
Price/Earnings12
Price/Book73
Dividend Yield—
Revenue Growth—
Profit Growth50
Capital Growth25
TSR 52w4
Leverage47
Liquidity31
Refinancing15
Combined—
Analyst Opinions9
Pro Holdings35
Opinion Changes7
Market Pulse32

Profile

CountryCanada
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Employees93
Websiteengene.com
ISINCA29286M1059
Last UpdateApr 2, 2026
Index & Theme
GeneticsImmunologyUrologyGenetic DisorderOncologyBiotechnologyHealth CareScience and Engineering

Description

enGene Therapeutics Inc. (enGene) operates as a clinical-stage biotechnology company that focuses on developing genetic medicines to improve the lives of patients suffering from bladder cancer. The company is developing non-viral genetic medicines b…

Similar Stocks

The companies this stock is ranked against.

Compare enGene with its peers
Protara Therapeutics
NMQ:TARA
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Beam Therapeutics
NSQ:BEAM
17
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Solid Biosciences
NSQ:SLDB
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Foghorn Therapeutics
NMQ:FHTX
49
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Benitec Biopharma
NAQ:BNTC
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Monte Rosa Therapeutics
NSQ:GLUE
13
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →